nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone Propionate—UGT1A1—Etoposide—urinary bladder cancer	0.109	1	CbGbCtD
Testosterone Propionate—AR—scrotum—urinary bladder cancer	0.0554	0.25	CbGeAlD
Testosterone Propionate—UGT1A1—urine—urinary bladder cancer	0.0284	0.128	CbGeAlD
Testosterone Propionate—AR—penis—urinary bladder cancer	0.025	0.113	CbGeAlD
Testosterone Propionate—UGT1A1—prostate gland—urinary bladder cancer	0.0102	0.046	CbGeAlD
Testosterone Propionate—COMT—prostate gland—urinary bladder cancer	0.00816	0.0367	CbGeAlD
Testosterone Propionate—CYP17A1—renal system—urinary bladder cancer	0.00761	0.0343	CbGeAlD
Testosterone Propionate—UGT1A1—renal system—urinary bladder cancer	0.00696	0.0313	CbGeAlD
Testosterone Propionate—COMT—seminal vesicle—urinary bladder cancer	0.0069	0.0311	CbGeAlD
Testosterone Propionate—CYP17A1—female reproductive system—urinary bladder cancer	0.00609	0.0274	CbGeAlD
Testosterone Propionate—AR—prostate gland—urinary bladder cancer	0.00597	0.0269	CbGeAlD
Testosterone Propionate—COMT—smooth muscle tissue—urinary bladder cancer	0.00578	0.026	CbGeAlD
Testosterone Propionate—COMT—renal system—urinary bladder cancer	0.00556	0.025	CbGeAlD
Testosterone Propionate—COMT—urethra—urinary bladder cancer	0.00546	0.0246	CbGeAlD
Testosterone Propionate—AR—seminal vesicle—urinary bladder cancer	0.00505	0.0227	CbGeAlD
Testosterone Propionate—COMT—female reproductive system—urinary bladder cancer	0.00446	0.0201	CbGeAlD
Testosterone Propionate—AR—epithelium—urinary bladder cancer	0.00439	0.0198	CbGeAlD
Testosterone Propionate—AR—smooth muscle tissue—urinary bladder cancer	0.00423	0.019	CbGeAlD
Testosterone Propionate—AR—renal system—urinary bladder cancer	0.00407	0.0183	CbGeAlD
Testosterone Propionate—COMT—vagina—urinary bladder cancer	0.00403	0.0181	CbGeAlD
Testosterone Propionate—AR—urethra—urinary bladder cancer	0.004	0.018	CbGeAlD
Testosterone Propionate—CYP17A1—lymph node—urinary bladder cancer	0.00356	0.016	CbGeAlD
Testosterone Propionate—AR—female reproductive system—urinary bladder cancer	0.00326	0.0147	CbGeAlD
Testosterone Propionate—AR—vagina—urinary bladder cancer	0.00295	0.0133	CbGeAlD
Testosterone Propionate—COMT—lymph node—urinary bladder cancer	0.00261	0.0117	CbGeAlD
Testosterone Propionate—COMT—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00237	0.00775	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—UGT2B7—urinary bladder cancer	0.0023	0.00753	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00227	0.00742	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—CYP4B1—urinary bladder cancer	0.00216	0.00708	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00213	0.00698	CbGpPWpGaD
Testosterone Propionate—Ethynodiol—ESR1—urinary bladder cancer	0.00212	0.231	CrCbGaD
Testosterone Propionate—AR—Nuclear Receptors—ESR2—urinary bladder cancer	0.00208	0.0068	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—CYP4B1—urinary bladder cancer	0.00207	0.00678	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00204	0.00668	CbGpPWpGaD
Testosterone Propionate—COMT—Phase II conjugation—HPGDS—urinary bladder cancer	0.00197	0.00643	CbGpPWpGaD
Testosterone Propionate—COMT—Phase II conjugation—GSTT1—urinary bladder cancer	0.00191	0.00624	CbGpPWpGaD
Testosterone Propionate—AR—lymph node—urinary bladder cancer	0.00191	0.00859	CbGeAlD
Testosterone Propionate—Norgestimate—ESR1—urinary bladder cancer	0.0018	0.196	CrCbGaD
Testosterone Propionate—UGT1A1—Biological oxidations—GSTZ1—urinary bladder cancer	0.00166	0.00543	CbGpPWpGaD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—ESR2—urinary bladder cancer	0.00164	0.00537	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—UGT2B7—urinary bladder cancer	0.00164	0.00537	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.00164	0.00536	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—NQO1—urinary bladder cancer	0.0016	0.00522	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—GSTO2—urinary bladder cancer	0.00157	0.00515	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—NAT1—urinary bladder cancer	0.00157	0.00515	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00155	0.00508	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Phase II conjugation—NAT2—urinary bladder cancer	0.00147	0.00482	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—NAT2—urinary bladder cancer	0.00144	0.00471	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—UGT2B7—urinary bladder cancer	0.00144	0.00471	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00142	0.00464	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00142	0.00464	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—NAT2—urinary bladder cancer	0.00138	0.00451	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00136	0.00445	CbGpPWpGaD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—NCOR1—urinary bladder cancer	0.00135	0.00443	CbGpPWpGaD
Testosterone Propionate—COMT—Phase II conjugation—GSTP1—urinary bladder cancer	0.00132	0.00433	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP4B1—urinary bladder cancer	0.0013	0.00424	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00128	0.00418	CbGpPWpGaD
Testosterone Propionate—AR—Nuclear Receptors—ESR1—urinary bladder cancer	0.00126	0.00412	CbGpPWpGaD
Testosterone Propionate—COMT—Phase II conjugation—GSTM1—urinary bladder cancer	0.00122	0.00397	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Phase II conjugation—HPGDS—urinary bladder cancer	0.00118	0.00385	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—HPGDS—urinary bladder cancer	0.00115	0.00376	CbGpPWpGaD
Testosterone Propionate—AR—Nuclear Receptors—PPARG—urinary bladder cancer	0.00115	0.00376	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Phase II conjugation—GSTT1—urinary bladder cancer	0.00114	0.00374	CbGpPWpGaD
Testosterone Propionate—AR—FOXA1 transcription factor network—ESR1—urinary bladder cancer	0.00112	0.00367	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—GSTT1—urinary bladder cancer	0.00112	0.00365	CbGpPWpGaD
Testosterone Propionate—Levonorgestrel—ESR1—urinary bladder cancer	0.0011	0.12	CrCbGaD
Testosterone Propionate—CYP17A1—Biological oxidations—HPGDS—urinary bladder cancer	0.0011	0.0036	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—GSTT1—urinary bladder cancer	0.00107	0.0035	CbGpPWpGaD
Testosterone Propionate—Fluoxymesterone—ESR1—urinary bladder cancer	0.00105	0.115	CrCbGaD
Testosterone Propionate—Danazol—ESR1—urinary bladder cancer	0.001	0.109	CrCbGaD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—ESR1—urinary bladder cancer	0.000996	0.00326	CbGpPWpGaD
Testosterone Propionate—AR—FOXA1 transcription factor network—CREBBP—urinary bladder cancer	0.000982	0.00321	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000936	0.00306	CbGpPWpGaD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—CREBBP—urinary bladder cancer	0.000932	0.00305	CbGpPWpGaD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—RB1—urinary bladder cancer	0.000929	0.00304	CbGpPWpGaD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—PPARG—urinary bladder cancer	0.000909	0.00297	CbGpPWpGaD
Testosterone Propionate—Medroxyprogesterone Acetate—ESR1—urinary bladder cancer	0.000901	0.0983	CrCbGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—NCOR1—urinary bladder cancer	0.000876	0.00286	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—NAT2—urinary bladder cancer	0.000863	0.00282	CbGpPWpGaD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—SRC—urinary bladder cancer	0.000861	0.00282	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000851	0.00278	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of Androgen receptor activity—CREBBP—urinary bladder cancer	0.000847	0.00277	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—CCNE1—urinary bladder cancer	0.000837	0.00274	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—NCOR1—urinary bladder cancer	0.000812	0.00266	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000796	0.0026	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Phase II conjugation—GSTP1—urinary bladder cancer	0.000792	0.00259	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—urinary bladder cancer	0.00078	0.00255	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—GSTP1—urinary bladder cancer	0.000774	0.00253	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—TSC1—urinary bladder cancer	0.000768	0.00251	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000763	0.0025	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—GSTP1—urinary bladder cancer	0.000741	0.00242	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000731	0.00239	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Phase II conjugation—GSTM1—urinary bladder cancer	0.000728	0.00238	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000714	0.00233	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—GSTM1—urinary bladder cancer	0.000711	0.00233	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000709	0.00232	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000701	0.00229	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—urinary bladder cancer	0.000691	0.00226	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—HPGDS—urinary bladder cancer	0.00069	0.00225	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—urinary bladder cancer	0.000688	0.00225	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—GSTM1—urinary bladder cancer	0.000681	0.00223	CbGpPWpGaD
Testosterone Propionate—Drospirenone—PTGS2—urinary bladder cancer	0.000675	0.0736	CrCbGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000672	0.0022	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.000672	0.0022	CbGpPWpGaD
Testosterone Propionate—AR—FOXA1 transcription factor network—EP300—urinary bladder cancer	0.000669	0.00219	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—GSTT1—urinary bladder cancer	0.000669	0.00219	CbGpPWpGaD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—CDKN2A—urinary bladder cancer	0.000663	0.00217	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000639	0.00209	CbGpPWpGaD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—EP300—urinary bladder cancer	0.000635	0.00208	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—NQO1—urinary bladder cancer	0.000634	0.00207	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal haemorrhage—Epirubicin—urinary bladder cancer	0.000633	0.00179	CcSEcCtD
Testosterone Propionate—Myalgia—Cisplatin—urinary bladder cancer	0.000632	0.00178	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000632	0.00178	CcSEcCtD
Testosterone Propionate—Skin disorder—Gemcitabine—urinary bladder cancer	0.000631	0.00178	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Etoposide—urinary bladder cancer	0.000631	0.00178	CcSEcCtD
Testosterone Propionate—Anxiety—Cisplatin—urinary bladder cancer	0.00063	0.00178	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000627	0.00177	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000626	0.00177	CcSEcCtD
Testosterone Propionate—Liver function test abnormal—Methotrexate—urinary bladder cancer	0.000624	0.00176	CcSEcCtD
Testosterone Propionate—Discomfort—Cisplatin—urinary bladder cancer	0.000624	0.00176	CcSEcCtD
Testosterone Propionate—Increased appetite—Doxorubicin—urinary bladder cancer	0.000623	0.00176	CcSEcCtD
Testosterone Propionate—Urticaria—Thiotepa—urinary bladder cancer	0.000614	0.00173	CcSEcCtD
Testosterone Propionate—Malaise—Etoposide—urinary bladder cancer	0.000613	0.00173	CcSEcCtD
Testosterone Propionate—Dermatitis bullous—Doxorubicin—urinary bladder cancer	0.000613	0.00173	CcSEcCtD
Testosterone Propionate—Breast disorder—Methotrexate—urinary bladder cancer	0.000611	0.00173	CcSEcCtD
Testosterone Propionate—Abdominal pain—Thiotepa—urinary bladder cancer	0.000611	0.00172	CcSEcCtD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—HRAS—urinary bladder cancer	0.000606	0.00198	CbGpPWpGaD
Testosterone Propionate—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000606	0.00171	CcSEcCtD
Testosterone Propionate—Oedema—Cisplatin—urinary bladder cancer	0.000606	0.00171	CcSEcCtD
Testosterone Propionate—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.000605	0.00171	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—urinary bladder cancer	0.000604	0.00198	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—CREBBP—urinary bladder cancer	0.000603	0.00197	CbGpPWpGaD
Testosterone Propionate—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000594	0.00168	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000592	0.00167	CcSEcCtD
Testosterone Propionate—Skin disorder—Cisplatin—urinary bladder cancer	0.000588	0.00166	CcSEcCtD
Testosterone Propionate—Insomnia—Gemcitabine—urinary bladder cancer	0.000588	0.00166	CcSEcCtD
Testosterone Propionate—Hypertension—Etoposide—urinary bladder cancer	0.000587	0.00166	CcSEcCtD
Testosterone Propionate—Gastrointestinal haemorrhage—Doxorubicin—urinary bladder cancer	0.000585	0.00165	CcSEcCtD
Testosterone Propionate—Liver function test abnormal—Epirubicin—urinary bladder cancer	0.000584	0.00165	CcSEcCtD
Testosterone Propionate—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000583	0.00165	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000582	0.00164	CcSEcCtD
Testosterone Propionate—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000579	0.00164	CcSEcCtD
Testosterone Propionate—Insomnia—Fluorouracil—urinary bladder cancer	0.000578	0.00163	CcSEcCtD
Testosterone Propionate—AR—Regulation of Androgen receptor activity—EP300—urinary bladder cancer	0.000577	0.00189	CbGpPWpGaD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000575	0.00162	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000574	0.00188	CbGpPWpGaD
Testosterone Propionate—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000574	0.00162	CcSEcCtD
Testosterone Propionate—Discomfort—Etoposide—urinary bladder cancer	0.000572	0.00161	CcSEcCtD
Testosterone Propionate—Breast disorder—Epirubicin—urinary bladder cancer	0.000572	0.00161	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000571	0.00187	CbGpPWpGaD
Testosterone Propionate—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00057	0.00161	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000569	0.00161	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000561	0.00158	CcSEcCtD
Testosterone Propionate—AR—Regulation of Androgen receptor activity—SRC—urinary bladder cancer	0.000561	0.00183	CbGpPWpGaD
Testosterone Propionate—Fatigue—Gemcitabine—urinary bladder cancer	0.00056	0.00158	CcSEcCtD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—CCND1—urinary bladder cancer	0.00056	0.00183	CbGpPWpGaD
Testosterone Propionate—Confusional state—Etoposide—urinary bladder cancer	0.000559	0.00158	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—CREBBP—urinary bladder cancer	0.000559	0.00183	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.000558	0.00182	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—RB1—urinary bladder cancer	0.000557	0.00182	CbGpPWpGaD
Testosterone Propionate—Pain—Gemcitabine—urinary bladder cancer	0.000556	0.00157	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000555	0.00157	CcSEcCtD
Testosterone Propionate—Asthenia—Thiotepa—urinary bladder cancer	0.000554	0.00156	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000552	0.00156	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000552	0.00156	CcSEcCtD
Testosterone Propionate—Dysuria—Methotrexate—urinary bladder cancer	0.000546	0.00154	CcSEcCtD
Testosterone Propionate—Pruritus—Thiotepa—urinary bladder cancer	0.000546	0.00154	CcSEcCtD
Testosterone Propionate—Pain—Fluorouracil—urinary bladder cancer	0.000546	0.00154	CcSEcCtD
Testosterone Propionate—Paraesthesia—Cisplatin—urinary bladder cancer	0.000544	0.00154	CcSEcCtD
Testosterone Propionate—Liver function test abnormal—Doxorubicin—urinary bladder cancer	0.000541	0.00153	CcSEcCtD
Testosterone Propionate—Dyspnoea—Cisplatin—urinary bladder cancer	0.00054	0.00152	CcSEcCtD
Testosterone Propionate—Skin disorder—Etoposide—urinary bladder cancer	0.000539	0.00152	CcSEcCtD
Testosterone Propionate—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.000538	0.00152	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000535	0.00151	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—urinary bladder cancer	0.000533	0.00174	CbGpPWpGaD
Testosterone Propionate—Breast disorder—Doxorubicin—urinary bladder cancer	0.000529	0.00149	CcSEcCtD
Testosterone Propionate—UGT1A1—NRF2 pathway—GSTP1—urinary bladder cancer	0.000529	0.00173	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Thiotepa—urinary bladder cancer	0.000528	0.00149	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000526	0.00149	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000523	0.00148	CcSEcCtD
Testosterone Propionate—Progesterone—ESR1—urinary bladder cancer	0.000521	0.0568	CrCbGaD
Testosterone Propionate—Pain—Cisplatin—urinary bladder cancer	0.000518	0.00146	CcSEcCtD
Testosterone Propionate—Dysuria—Epirubicin—urinary bladder cancer	0.000511	0.00144	CcSEcCtD
Testosterone Propionate—Dizziness—Thiotepa—urinary bladder cancer	0.000511	0.00144	CcSEcCtD
Testosterone Propionate—Urticaria—Fluorouracil—urinary bladder cancer	0.000508	0.00143	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—RHOA—urinary bladder cancer	0.000506	0.00165	CbGpPWpGaD
Testosterone Propionate—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000499	0.00141	CcSEcCtD
Testosterone Propionate—Paraesthesia—Etoposide—urinary bladder cancer	0.000498	0.00141	CcSEcCtD
Testosterone Propionate—Weight increased—Epirubicin—urinary bladder cancer	0.000498	0.00141	CcSEcCtD
Testosterone Propionate—Haematuria—Methotrexate—urinary bladder cancer	0.000497	0.0014	CcSEcCtD
Testosterone Propionate—Dyspnoea—Etoposide—urinary bladder cancer	0.000495	0.0014	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000493	0.00139	CcSEcCtD
Testosterone Propionate—Vomiting—Thiotepa—urinary bladder cancer	0.000491	0.00139	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000489	0.0016	CbGpPWpGaD
Testosterone Propionate—Rash—Thiotepa—urinary bladder cancer	0.000487	0.00138	CcSEcCtD
Testosterone Propionate—Dermatitis—Thiotepa—urinary bladder cancer	0.000487	0.00137	CcSEcCtD
Testosterone Propionate—UGT1A1—NRF2 pathway—GSTM1—urinary bladder cancer	0.000486	0.00159	CbGpPWpGaD
Testosterone Propionate—Headache—Thiotepa—urinary bladder cancer	0.000484	0.00137	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—urinary bladder cancer	0.000484	0.00158	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000479	0.00135	CcSEcCtD
Testosterone Propionate—Fatigue—Etoposide—urinary bladder cancer	0.000478	0.00135	CcSEcCtD
Testosterone Propionate—Pain—Etoposide—urinary bladder cancer	0.000474	0.00134	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—GSTZ1—urinary bladder cancer	0.000474	0.00155	CbGpPWpGaD
Testosterone Propionate—Dysuria—Doxorubicin—urinary bladder cancer	0.000473	0.00134	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000471	0.00133	CcSEcCtD
Testosterone Propionate—Haemoglobin—Methotrexate—urinary bladder cancer	0.00047	0.00133	CcSEcCtD
Testosterone Propionate—Haemorrhage—Methotrexate—urinary bladder cancer	0.000468	0.00132	CcSEcCtD
Testosterone Propionate—Asthenia—Gemcitabine—urinary bladder cancer	0.000466	0.00132	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000466	0.00152	CbGpPWpGaD
Testosterone Propionate—Haematuria—Epirubicin—urinary bladder cancer	0.000465	0.00131	CcSEcCtD
Testosterone Propionate—UGT1A1—Biological oxidations—GSTP1—urinary bladder cancer	0.000464	0.00152	CbGpPWpGaD
Testosterone Propionate—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000462	0.0013	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000461	0.0013	CcSEcCtD
Testosterone Propionate—Weight increased—Doxorubicin—urinary bladder cancer	0.000461	0.0013	CcSEcCtD
Testosterone Propionate—Pruritus—Gemcitabine—urinary bladder cancer	0.00046	0.0013	CcSEcCtD
Testosterone Propionate—Nausea—Thiotepa—urinary bladder cancer	0.000459	0.0013	CcSEcCtD
Testosterone Propionate—Urethral disorder—Methotrexate—urinary bladder cancer	0.000459	0.00129	CcSEcCtD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000457	0.00149	CbGpPWpGaD
Testosterone Propionate—Feeling abnormal—Etoposide—urinary bladder cancer	0.000457	0.00129	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000454	0.00149	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GSTZ1—urinary bladder cancer	0.000454	0.00148	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000454	0.00128	CcSEcCtD
Testosterone Propionate—Pruritus—Fluorouracil—urinary bladder cancer	0.000452	0.00128	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—urinary bladder cancer	0.000451	0.00147	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GSTO2—urinary bladder cancer	0.000449	0.00147	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—NAT1—urinary bladder cancer	0.000449	0.00147	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000446	0.00126	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000446	0.00146	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000445	0.00126	CcSEcCtD
Testosterone Propionate—Urticaria—Etoposide—urinary bladder cancer	0.000441	0.00124	CcSEcCtD
Testosterone Propionate—Haemoglobin—Epirubicin—urinary bladder cancer	0.00044	0.00124	CcSEcCtD
Testosterone Propionate—Abdominal pain—Etoposide—urinary bladder cancer	0.000439	0.00124	CcSEcCtD
Testosterone Propionate—Haemorrhage—Epirubicin—urinary bladder cancer	0.000438	0.00124	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—urinary bladder cancer	0.000437	0.00143	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000437	0.00123	CcSEcCtD
Testosterone Propionate—Asthenia—Cisplatin—urinary bladder cancer	0.000435	0.00123	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000432	0.00122	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—urinary bladder cancer	0.000432	0.00141	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GSTO2—urinary bladder cancer	0.00043	0.00141	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—NAT1—urinary bladder cancer	0.00043	0.00141	CbGpPWpGaD
Testosterone Propionate—Haematuria—Doxorubicin—urinary bladder cancer	0.00043	0.00121	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.00043	0.00121	CcSEcCtD
Testosterone Propionate—Urethral disorder—Epirubicin—urinary bladder cancer	0.000429	0.00121	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000427	0.0012	CcSEcCtD
Testosterone Propionate—UGT1A1—Biological oxidations—GSTM1—urinary bladder cancer	0.000426	0.00139	CbGpPWpGaD
Testosterone Propionate—Angiopathy—Methotrexate—urinary bladder cancer	0.000424	0.0012	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000423	0.00138	CbGpPWpGaD
Testosterone Propionate—Immune system disorder—Methotrexate—urinary bladder cancer	0.000423	0.00119	CcSEcCtD
Testosterone Propionate—Dizziness—Fluorouracil—urinary bladder cancer	0.000422	0.00119	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000422	0.00119	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—ATM—urinary bladder cancer	0.000422	0.00138	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.00042	0.00137	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CDK4—urinary bladder cancer	0.00042	0.00137	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—ESR1—urinary bladder cancer	0.000418	0.00137	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—urinary bladder cancer	0.000415	0.00136	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Cisplatin—urinary bladder cancer	0.000414	0.00117	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—CCND1—urinary bladder cancer	0.000414	0.00135	CbGpPWpGaD
Testosterone Propionate—Alopecia—Methotrexate—urinary bladder cancer	0.000413	0.00117	CcSEcCtD
Testosterone Propionate—Vomiting—Gemcitabine—urinary bladder cancer	0.000413	0.00117	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—UGT2B7—urinary bladder cancer	0.000411	0.00134	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—EP300—urinary bladder cancer	0.000411	0.00134	CbGpPWpGaD
Testosterone Propionate—Mental disorder—Methotrexate—urinary bladder cancer	0.00041	0.00116	CcSEcCtD
Testosterone Propionate—Rash—Gemcitabine—urinary bladder cancer	0.00041	0.00116	CcSEcCtD
Testosterone Propionate—Dermatitis—Gemcitabine—urinary bladder cancer	0.000409	0.00116	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Etoposide—urinary bladder cancer	0.000409	0.00115	CcSEcCtD
Testosterone Propionate—Malnutrition—Methotrexate—urinary bladder cancer	0.000407	0.00115	CcSEcCtD
Testosterone Propionate—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000407	0.00115	CcSEcCtD
Testosterone Propionate—Headache—Gemcitabine—urinary bladder cancer	0.000407	0.00115	CcSEcCtD
Testosterone Propionate—Vomiting—Fluorouracil—urinary bladder cancer	0.000406	0.00115	CcSEcCtD
Testosterone Propionate—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000405	0.00114	CcSEcCtD
Testosterone Propionate—Rash—Fluorouracil—urinary bladder cancer	0.000403	0.00114	CcSEcCtD
Testosterone Propionate—Dermatitis—Fluorouracil—urinary bladder cancer	0.000402	0.00114	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—CDKN1A—urinary bladder cancer	0.0004	0.00131	CbGpPWpGaD
Testosterone Propionate—Headache—Fluorouracil—urinary bladder cancer	0.0004	0.00113	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.0004	0.00113	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—PTEN—urinary bladder cancer	0.000399	0.00131	CbGpPWpGaD
Testosterone Propionate—Asthenia—Etoposide—urinary bladder cancer	0.000398	0.00112	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000398	0.00112	CcSEcCtD
Testosterone Propionate—Angiopathy—Epirubicin—urinary bladder cancer	0.000397	0.00112	CcSEcCtD
Testosterone Propionate—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000397	0.00112	CcSEcCtD
Testosterone Propionate—Immune system disorder—Epirubicin—urinary bladder cancer	0.000395	0.00112	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.000395	0.00129	CbGpPWpGaD
Testosterone Propionate—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000395	0.00111	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—UGT2B7—urinary bladder cancer	0.000394	0.00129	CbGpPWpGaD
Testosterone Propionate—Pruritus—Etoposide—urinary bladder cancer	0.000393	0.00111	CcSEcCtD
Testosterone Propionate—Alopecia—Epirubicin—urinary bladder cancer	0.000387	0.00109	CcSEcCtD
Testosterone Propionate—Nausea—Gemcitabine—urinary bladder cancer	0.000386	0.00109	CcSEcCtD
Testosterone Propionate—Vomiting—Cisplatin—urinary bladder cancer	0.000385	0.00109	CcSEcCtD
Testosterone Propionate—Mental disorder—Epirubicin—urinary bladder cancer	0.000384	0.00108	CcSEcCtD
Testosterone Propionate—Rash—Cisplatin—urinary bladder cancer	0.000382	0.00108	CcSEcCtD
Testosterone Propionate—Dermatitis—Cisplatin—urinary bladder cancer	0.000381	0.00108	CcSEcCtD
Testosterone Propionate—Malnutrition—Epirubicin—urinary bladder cancer	0.000381	0.00108	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—EP300—urinary bladder cancer	0.000381	0.00125	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Etoposide—urinary bladder cancer	0.00038	0.00107	CcSEcCtD
Testosterone Propionate—Nausea—Fluorouracil—urinary bladder cancer	0.000379	0.00107	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000378	0.00107	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—SRC—urinary bladder cancer	0.00037	0.00121	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYP4B1—urinary bladder cancer	0.00037	0.00121	CbGpPWpGaD
Testosterone Propionate—Angiopathy—Doxorubicin—urinary bladder cancer	0.000367	0.00104	CcSEcCtD
Testosterone Propionate—Malaise—Methotrexate—urinary bladder cancer	0.000367	0.00104	CcSEcCtD
Testosterone Propionate—Dizziness—Etoposide—urinary bladder cancer	0.000367	0.00104	CcSEcCtD
Testosterone Propionate—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000366	0.00103	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000365	0.00103	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—RB1—urinary bladder cancer	0.000365	0.00119	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CDH1—urinary bladder cancer	0.000364	0.00119	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—urinary bladder cancer	0.000361	0.00118	CbGpPWpGaD
Testosterone Propionate—Nausea—Cisplatin—urinary bladder cancer	0.00036	0.00102	CcSEcCtD
Testosterone Propionate—Alopecia—Doxorubicin—urinary bladder cancer	0.000358	0.00101	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—urinary bladder cancer	0.000358	0.00117	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000357	0.00117	CbGpPWpGaD
Testosterone Propionate—Mental disorder—Doxorubicin—urinary bladder cancer	0.000355	0.001	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—CYP4B1—urinary bladder cancer	0.000354	0.00116	CbGpPWpGaD
Testosterone Propionate—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000354	0.000998	CcSEcCtD
Testosterone Propionate—Vomiting—Etoposide—urinary bladder cancer	0.000353	0.000996	CcSEcCtD
Testosterone Propionate—Malnutrition—Doxorubicin—urinary bladder cancer	0.000353	0.000996	CcSEcCtD
Testosterone Propionate—Rash—Etoposide—urinary bladder cancer	0.00035	0.000988	CcSEcCtD
Testosterone Propionate—Dermatitis—Etoposide—urinary bladder cancer	0.000349	0.000987	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—SLC19A1—urinary bladder cancer	0.000349	0.00114	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.000349	0.00114	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.000348	0.00114	CbGpPWpGaD
Testosterone Propionate—Headache—Etoposide—urinary bladder cancer	0.000348	0.000981	CcSEcCtD
Testosterone Propionate—Arthralgia—Methotrexate—urinary bladder cancer	0.000347	0.000979	CcSEcCtD
Testosterone Propionate—Myalgia—Methotrexate—urinary bladder cancer	0.000347	0.000979	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	0.000346	0.00113	CbGpPWpGaD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000344	0.000972	CcSEcCtD
Testosterone Propionate—Malaise—Epirubicin—urinary bladder cancer	0.000344	0.00097	CcSEcCtD
Testosterone Propionate—Discomfort—Methotrexate—urinary bladder cancer	0.000343	0.000967	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—PRSS3—urinary bladder cancer	0.000341	0.00111	CbGpPWpGaD
Testosterone Propionate—Confusional state—Methotrexate—urinary bladder cancer	0.000335	0.000946	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—SLC19A1—urinary bladder cancer	0.000335	0.00109	CbGpPWpGaD
Testosterone Propionate—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000332	0.000938	CcSEcCtD
Testosterone Propionate—Nausea—Etoposide—urinary bladder cancer	0.00033	0.000931	CcSEcCtD
Testosterone Propionate—Hypertension—Epirubicin—urinary bladder cancer	0.000329	0.000929	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000327	0.000924	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—PRSS3—urinary bladder cancer	0.000326	0.00107	CbGpPWpGaD
Testosterone Propionate—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000326	0.00092	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—EGFR—urinary bladder cancer	0.000325	0.00106	CbGpPWpGaD
Testosterone Propionate—Arthralgia—Epirubicin—urinary bladder cancer	0.000324	0.000916	CcSEcCtD
Testosterone Propionate—Myalgia—Epirubicin—urinary bladder cancer	0.000324	0.000916	CcSEcCtD
Testosterone Propionate—Anxiety—Epirubicin—urinary bladder cancer	0.000323	0.000913	CcSEcCtD
Testosterone Propionate—Skin disorder—Methotrexate—urinary bladder cancer	0.000323	0.000911	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000322	0.00091	CcSEcCtD
Testosterone Propionate—Discomfort—Epirubicin—urinary bladder cancer	0.000321	0.000905	CcSEcCtD
Testosterone Propionate—Malaise—Doxorubicin—urinary bladder cancer	0.000318	0.000898	CcSEcCtD
Testosterone Propionate—Confusional state—Epirubicin—urinary bladder cancer	0.000314	0.000885	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000311	0.000878	CcSEcCtD
Testosterone Propionate—Oedema—Epirubicin—urinary bladder cancer	0.000311	0.000878	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000305	0.000861	CcSEcCtD
Testosterone Propionate—Hypertension—Doxorubicin—urinary bladder cancer	0.000304	0.00086	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.000304	0.000993	CbGpPWpGaD
Testosterone Propionate—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000303	0.000855	CcSEcCtD
Testosterone Propionate—Skin disorder—Epirubicin—urinary bladder cancer	0.000302	0.000853	CcSEcCtD
Testosterone Propionate—Insomnia—Methotrexate—urinary bladder cancer	0.000301	0.000849	CcSEcCtD
Testosterone Propionate—Arthralgia—Doxorubicin—urinary bladder cancer	0.0003	0.000848	CcSEcCtD
Testosterone Propionate—Myalgia—Doxorubicin—urinary bladder cancer	0.0003	0.000848	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.0003	0.00098	CbGpPWpGaD
Testosterone Propionate—Anxiety—Doxorubicin—urinary bladder cancer	0.000299	0.000845	CcSEcCtD
Testosterone Propionate—Paraesthesia—Methotrexate—urinary bladder cancer	0.000298	0.000843	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000298	0.000842	CcSEcCtD
Testosterone Propionate—Discomfort—Doxorubicin—urinary bladder cancer	0.000297	0.000837	CcSEcCtD
Testosterone Propionate—Dyspnoea—Methotrexate—urinary bladder cancer	0.000296	0.000837	CcSEcCtD
Testosterone Propionate—Confusional state—Doxorubicin—urinary bladder cancer	0.00029	0.000819	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000288	0.000813	CcSEcCtD
Testosterone Propionate—Oedema—Doxorubicin—urinary bladder cancer	0.000288	0.000813	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000287	0.00081	CcSEcCtD
Testosterone Propionate—Fatigue—Methotrexate—urinary bladder cancer	0.000287	0.000809	CcSEcCtD
Testosterone Propionate—Pain—Methotrexate—urinary bladder cancer	0.000284	0.000802	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—GSTZ1—urinary bladder cancer	0.000284	0.000929	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000284	0.000928	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000283	0.000927	CbGpPWpGaD
Testosterone Propionate—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000283	0.0008	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000282	0.000797	CcSEcCtD
Testosterone Propionate—Insomnia—Epirubicin—urinary bladder cancer	0.000281	0.000794	CcSEcCtD
Testosterone Propionate—Skin disorder—Doxorubicin—urinary bladder cancer	0.00028	0.000789	CcSEcCtD
Testosterone Propionate—Paraesthesia—Epirubicin—urinary bladder cancer	0.000279	0.000789	CcSEcCtD
Testosterone Propionate—Dyspnoea—Epirubicin—urinary bladder cancer	0.000277	0.000783	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000274	0.000773	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—TYMP—urinary bladder cancer	0.000272	0.00089	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000272	0.000767	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CCND1—urinary bladder cancer	0.000271	0.000886	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTO2—urinary bladder cancer	0.000269	0.00088	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—NAT1—urinary bladder cancer	0.000269	0.00088	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000268	0.000758	CcSEcCtD
Testosterone Propionate—Fatigue—Epirubicin—urinary bladder cancer	0.000268	0.000757	CcSEcCtD
Testosterone Propionate—Pain—Epirubicin—urinary bladder cancer	0.000266	0.000751	CcSEcCtD
Testosterone Propionate—Urticaria—Methotrexate—urinary bladder cancer	0.000264	0.000745	CcSEcCtD
Testosterone Propionate—Abdominal pain—Methotrexate—urinary bladder cancer	0.000263	0.000742	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000262	0.00074	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—PTEN—urinary bladder cancer	0.000262	0.000855	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000262	0.000855	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—TYMP—urinary bladder cancer	0.000261	0.000853	CbGpPWpGaD
Testosterone Propionate—Insomnia—Doxorubicin—urinary bladder cancer	0.00026	0.000735	CcSEcCtD
Testosterone Propionate—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000258	0.00073	CcSEcCtD
Testosterone Propionate—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000257	0.000724	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000256	0.000724	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000254	0.000718	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	0.000254	0.000831	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.00025	0.000819	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—EP300—urinary bladder cancer	0.00025	0.000816	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	0.000249	0.000813	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000248	0.000701	CcSEcCtD
Testosterone Propionate—Fatigue—Doxorubicin—urinary bladder cancer	0.000248	0.000701	CcSEcCtD
Testosterone Propionate—Urticaria—Epirubicin—urinary bladder cancer	0.000247	0.000698	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—UGT2B7—urinary bladder cancer	0.000246	0.000805	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—NAT2—urinary bladder cancer	0.000246	0.000805	CbGpPWpGaD
Testosterone Propionate—Pain—Doxorubicin—urinary bladder cancer	0.000246	0.000695	CcSEcCtD
Testosterone Propionate—Abdominal pain—Epirubicin—urinary bladder cancer	0.000246	0.000694	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000245	0.000691	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000243	0.000795	CbGpPWpGaD
Testosterone Propionate—Asthenia—Methotrexate—urinary bladder cancer	0.000238	0.000673	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000237	0.00067	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—NAT2—urinary bladder cancer	0.000236	0.000771	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000235	0.000664	CcSEcCtD
Testosterone Propionate—Pruritus—Methotrexate—urinary bladder cancer	0.000235	0.000664	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000229	0.000647	CcSEcCtD
Testosterone Propionate—Urticaria—Doxorubicin—urinary bladder cancer	0.000229	0.000645	CcSEcCtD
Testosterone Propionate—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000227	0.000642	CcSEcCtD
Testosterone Propionate—Diarrhoea—Methotrexate—urinary bladder cancer	0.000227	0.000642	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	0.000225	0.000734	CbGpPWpGaD
Testosterone Propionate—Asthenia—Epirubicin—urinary bladder cancer	0.000223	0.00063	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—CYP4B1—urinary bladder cancer	0.000222	0.000725	CbGpPWpGaD
Testosterone Propionate—Pruritus—Epirubicin—urinary bladder cancer	0.00022	0.000621	CcSEcCtD
Testosterone Propionate—Dizziness—Methotrexate—urinary bladder cancer	0.00022	0.000621	CcSEcCtD
Testosterone Propionate—AR—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000219	0.000716	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	0.000217	0.000711	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	0.000217	0.00071	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	0.000217	0.000709	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Epirubicin—urinary bladder cancer	0.000213	0.000601	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	0.000213	0.000695	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—RRM2—urinary bladder cancer	0.000213	0.000695	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000212	0.000599	CcSEcCtD
Testosterone Propionate—Vomiting—Methotrexate—urinary bladder cancer	0.000211	0.000597	CcSEcCtD
Testosterone Propionate—Rash—Methotrexate—urinary bladder cancer	0.00021	0.000592	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—SLC19A1—urinary bladder cancer	0.000209	0.000685	CbGpPWpGaD
Testosterone Propionate—Dermatitis—Methotrexate—urinary bladder cancer	0.000209	0.000591	CcSEcCtD
Testosterone Propionate—Headache—Methotrexate—urinary bladder cancer	0.000208	0.000588	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	0.000207	0.000676	CbGpPWpGaD
Testosterone Propionate—Asthenia—Doxorubicin—urinary bladder cancer	0.000206	0.000583	CcSEcCtD
Testosterone Propionate—Dizziness—Epirubicin—urinary bladder cancer	0.000206	0.000581	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—PRSS3—urinary bladder cancer	0.000204	0.000667	CbGpPWpGaD
Testosterone Propionate—Pruritus—Doxorubicin—urinary bladder cancer	0.000204	0.000575	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—RRM2—urinary bladder cancer	0.000204	0.000666	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000202	0.000661	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	0.000201	0.000657	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	0.000201	0.000657	CbGpPWpGaD
Testosterone Propionate—Vomiting—Epirubicin—urinary bladder cancer	0.000198	0.000558	CcSEcCtD
Testosterone Propionate—Nausea—Methotrexate—urinary bladder cancer	0.000197	0.000557	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000197	0.000645	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000197	0.000556	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—ENO2—urinary bladder cancer	0.000197	0.000644	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—HPGDS—urinary bladder cancer	0.000197	0.000644	CbGpPWpGaD
Testosterone Propionate—Rash—Epirubicin—urinary bladder cancer	0.000196	0.000554	CcSEcCtD
Testosterone Propionate—Dermatitis—Epirubicin—urinary bladder cancer	0.000196	0.000553	CcSEcCtD
Testosterone Propionate—Headache—Epirubicin—urinary bladder cancer	0.000195	0.00055	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—GSTT1—urinary bladder cancer	0.000191	0.000624	CbGpPWpGaD
Testosterone Propionate—Dizziness—Doxorubicin—urinary bladder cancer	0.00019	0.000537	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—ENO2—urinary bladder cancer	0.000189	0.000616	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—HPGDS—urinary bladder cancer	0.000189	0.000616	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000187	0.000613	CbGpPWpGaD
Testosterone Propionate—Nausea—Epirubicin—urinary bladder cancer	0.000185	0.000522	CcSEcCtD
Testosterone Propionate—Vomiting—Doxorubicin—urinary bladder cancer	0.000183	0.000517	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—GSTT1—urinary bladder cancer	0.000183	0.000598	CbGpPWpGaD
Testosterone Propionate—Rash—Doxorubicin—urinary bladder cancer	0.000181	0.000512	CcSEcCtD
Testosterone Propionate—Dermatitis—Doxorubicin—urinary bladder cancer	0.000181	0.000512	CcSEcCtD
Testosterone Propionate—Headache—Doxorubicin—urinary bladder cancer	0.00018	0.000509	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	0.00018	0.000589	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.00018	0.000589	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	0.000179	0.000584	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	0.000176	0.000576	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000172	0.000563	CbGpPWpGaD
Testosterone Propionate—Nausea—Doxorubicin—urinary bladder cancer	0.000171	0.000483	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	0.000168	0.000549	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	0.000166	0.000544	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—TYMP—urinary bladder cancer	0.000163	0.000533	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—NQO1—urinary bladder cancer	0.000159	0.000519	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000157	0.000513	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—SMC1A—urinary bladder cancer	0.000157	0.000512	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—HRAS—urinary bladder cancer	0.000155	0.000507	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—NQO1—urinary bladder cancer	0.000152	0.000497	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000151	0.000493	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	0.000148	0.000484	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—NAT2—urinary bladder cancer	0.000148	0.000482	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000147	0.000482	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—ESR2—urinary bladder cancer	0.000137	0.000447	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GSTP1—urinary bladder cancer	0.000132	0.000433	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000129	0.00042	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—RRM2—urinary bladder cancer	0.000127	0.000416	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GSTP1—urinary bladder cancer	0.000127	0.000414	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—TYMS—urinary bladder cancer	0.000123	0.000402	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000123	0.000401	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GSTM1—urinary bladder cancer	0.000122	0.000398	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—NCOR1—urinary bladder cancer	0.000122	0.000398	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—HPGDS—urinary bladder cancer	0.000118	0.000386	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ENO2—urinary bladder cancer	0.000118	0.000386	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—TYMS—urinary bladder cancer	0.000118	0.000385	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—NCOR1—urinary bladder cancer	0.000116	0.000381	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GSTM1—urinary bladder cancer	0.000116	0.000381	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GPX1—urinary bladder cancer	0.000116	0.000381	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTT1—urinary bladder cancer	0.000114	0.000374	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ERCC2—urinary bladder cancer	0.000114	0.000374	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GPX1—urinary bladder cancer	0.000112	0.000365	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ERCC2—urinary bladder cancer	0.000109	0.000358	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—MTHFR—urinary bladder cancer	0.000107	0.000351	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—NCOR1—urinary bladder cancer	0.000105	0.000345	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—MTHFR—urinary bladder cancer	0.000103	0.000337	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—ERCC2—urinary bladder cancer	9.92e-05	0.000324	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—NQO1—urinary bladder cancer	9.51e-05	0.000311	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—MYC—urinary bladder cancer	8.95e-05	0.000293	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PPARG—urinary bladder cancer	8.72e-05	0.000285	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CREBBP—urinary bladder cancer	8.37e-05	0.000274	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PPARG—urinary bladder cancer	8.35e-05	0.000273	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—ESR1—urinary bladder cancer	8.28e-05	0.000271	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CREBBP—urinary bladder cancer	8.02e-05	0.000262	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTP1—urinary bladder cancer	7.93e-05	0.000259	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—PPARG—urinary bladder cancer	7.56e-05	0.000247	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—TYMS—urinary bladder cancer	7.37e-05	0.000241	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—NCOR1—urinary bladder cancer	7.29e-05	0.000238	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTM1—urinary bladder cancer	7.29e-05	0.000238	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—CREBBP—urinary bladder cancer	7.26e-05	0.000237	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GPX1—urinary bladder cancer	6.98e-05	0.000228	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PTGS2—urinary bladder cancer	6.86e-05	0.000224	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ERCC2—urinary bladder cancer	6.85e-05	0.000224	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PTGS2—urinary bladder cancer	6.57e-05	0.000215	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—MTHFR—urinary bladder cancer	6.44e-05	0.000211	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PTEN—urinary bladder cancer	5.98e-05	0.000195	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PTEN—urinary bladder cancer	5.73e-05	0.000187	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—EP300—urinary bladder cancer	5.7e-05	0.000186	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—EP300—urinary bladder cancer	5.46e-05	0.000179	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PPARG—urinary bladder cancer	5.22e-05	0.000171	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CREBBP—urinary bladder cancer	5.02e-05	0.000164	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—MYC—urinary bladder cancer	4.31e-05	0.000141	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PTGS2—urinary bladder cancer	4.11e-05	0.000134	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PTEN—urinary bladder cancer	3.58e-05	0.000117	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—EP300—urinary bladder cancer	3.42e-05	0.000112	CbGpPWpGaD
